[1]
2021. Use of levosimendan versus dobutamine when inotropic support is needed in patients with severe acute decompensated chronic heart failure. Ukrainian Journal of Cardiology. 27, 6 (Feb. 2021), 47–60. DOI:https://doi.org/10.31928/1608-635X-2020.6.4760.